Alkem Becomes First Indian Company To Launch Novel Antibiotic For Multiple Drug Resistance (MDR) Infections The available evidence suggests that Zidavi is a potential therapeutic option for the treatment of infections complicated by multi-drug resistant (MDR) organisms

By Teena Jose

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Pexels

Alkem (Intenza, critical care division) has announced the launch of its novel anti-infective in India under the brand name Zidavi. This is in line with company's endeavour to ensure affordability, accessibility, and availability while saving the lives of critically ill patients.

Zidavi, which is a novel combination of ceftazidime and avibactam, is recommended by the infectious disease society of America (IDSA) and the Indian council of medical research (ICMR) as a preferred treatment against OXA-48-like and Klebsiella pneumoniae carbapenemase (KPC)-producing carbapenem-resistant Enterobacteriaceae (CRE) for pyelonephritis or complicated urinary tract infections (cUTI) and in other CRE infections caused by KPC and OXA-48 producers.

"With the launch of Zidavi, our aim is to ensure that Alkem continues to remain at the forefront while partnering with clinicians for saving lives," said company spokesperson.

With the rise in infections caused by carbapenem-resistant Gram-negative organisms in India, there is a need for more effective antibiotic treatment. The available evidence suggests that Zidavi (ceftazidime-avibactam) is a potential therapeutic option for the treatment of infections complicated by multi-drug resistant (MDR) organisms. Zidavi 2.5g (ceftazidime and avibactam) for infusion is available as a sterile powdered concentrate for reconstitution. Each single-dose vial contains ceftazidime pentahydrate equivalent to 2g ceftazidime and avibactam sodium equivalent to 0.5g avibactam. It is available at an affordable price of INR 2,700/vial. Zidavi's strength lies in its indigenously developed (Active Pharmaceutical Ingredients) API, which is manufactured in the company's state-of-the-art manufacturing plant in Sikkim, the statement added, according to statement given by the company.

Alkem is a leading Indian global pharmaceutical company that manufactures and markets bio-similars and pharmaceutical formulations in India and across the globe.
Teena Jose

News Desk Reporter with Entrepreneur India

Teena is a post graduate in financial journalism. She has an avid interest in content creation, digital media and fashion.
Leadership

From Barista to CEO: A Conversation With Smashburger's Leader on Her Inspiring Journey, How She's Transforming the Brand and Her Vision for the Future

Denise Nelsen, CEO of Smashburger, reflects on her journey from Starbucks barista to the leader of one of the most popular brands in the fast-casual dining industry, reveals the exciting changes being implemented at the company and offers advice for aspiring executives.

Franchise

How This Franchise Grew 70% in 3 Years and Became the Top Choice in Tech

Wireless Zone, #1 in the tech category of the Franchise 500, is redefining wireless retail with cutting-edge technology and franchisee support.

Leadership

The 2025 Leadership Playbook — Strategies to Help You Thrive in Uncertain Times

How to lead through uncertainty, adapt to challenges and position your organization for lasting success.

Marketing

7 Local SEO Strategies I've Used to Help Businesses Boost Their Revenue 10x — Especially Blue-Collar Companies

Discover actionable local SEO strategies for service-based businesses like pest control or auto glass repair. Boost visibility, reviews and leads with these tips.